In this case, we consider the erythroderma to have been a paraneoplastic effect of the prostate carcinoma. In male patients with erythroderma an early PSA test should be performed.
This study suggests that both the "high dose" and the "medium dose" regimens are effective in the treatment of patients with acutely exacerbated atopic dermatitis.
In a controlled prospective study we compared the efficacy of combined salt water bath and UVA/B phototherapy to a UVA/B mono-phototherapy in patients with subacute atopic dermatitis (AD). The patients in the balneophototherapy group (n=16) were treated with baths containing 3-5% of the synthetic salt Psori-sal(trade mark), followed immediately by UVA/B irradiation, while the other treatment arm (n=12) received UVA/B phototherapy alone. After 20 treatments the balneophototherapy group showed a statistically significant (p=0.0015) reduction of the SCORAD score from 69.5 before to 36.8 after therapy. No statistically significant reduction in the SCORAD score could be observed in the UVA/B phototherapy group (50.6 before to 44.3 after therapy). The cumulative UVB dose was significantly lower in the balneophototherapy group (0.9 J/cm2) as compared to the UVA/B monotherapy group (2.0 J/cm2). Balneophototherapy was well tolerated by patients with atopic dermatitis and no side effects were observed. We conclude that balneophototherapy expands the therapeutic options for patients with subacute atopic dermatitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.